IL7 and diabetes mellitus: In humans, polymorphisms of the IL-7R alpha were associated with an increased risk of developing the disease [36], and nonenzymatic glycation of the IL-7R alpha in patients with established diabetes and hyperglycemia appear to affect IL-7 signaling [37].